Antimicrobial Agents and Chemotherapy, April 1998, p. 956-958, Vol. 42, No. 4
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Public Health Research Institute, New York, New York 10016,1 and Parke-Davis, Pharmaceutical Research Division, Warner Lambert Company, Ann Arbor, Michigan 481052
Received 15 September 1997/Returned for modification 4 December 1997/Accepted 22 January 1998
C-8-methoxy fluoroquinolones were more lethal than C-8-bromine, C-8-ethoxy, and C-8-H derivatives for Staphylococcus aureus, especially when topoisomerase IV was resistant. The methoxy group also increased lethality against wild-type cells when protein synthesis was inhibited. These properties encourage refinement of C-8-methoxy fluoroquinolones to kill staphylococci.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |